Ensign Peak Advisors, Inc
Position in ELDN — Eledon Pharmaceuticals, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in ELDN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,278,822
+$686,872 QoQ
Shares Held
2,101,224
-14.8% QoQ
Ownership
2.59%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 159 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. ELDN ranks #36 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in ELDN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,278,822 | 2,101,224 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,591,950 | 2,464,919 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,722,027 | 2,464,919 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,276,140 | 1,264,919 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,427,930 | 1,264,919 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,288,075 | 1,264,919 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,211,466 | 1,264,919 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,103,072 | 443,001 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,169,522 | 443,001 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $912,582 | 443,001 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $797,401 | 443,001 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $606,911 | 443,001 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $606,911 | 443,001 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,045,482 | 443,001 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,010,042 | 443,001 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $240,909 | 87,286 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $188,124 | 77,100 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $303,774 | 77,100 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $340,011 | 77,100 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $44,669 | 7,228 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $285,638 | 36,111 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $386,387 | 36,111 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $556,109 | 36,111 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 NVUS | — | 650,000 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||